Centrosome Analysis in Breast Tumors
Author Information
Author(s): Guo Hui-qin, Gao Meixia, Ma Jinfang, Xiao Ting, Zhao Lin-lin, Gao Yanning, Pan Qin-jing
Primary Institution: Cancer Institute/Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences
Hypothesis
Are centrosome amplifications present in breast tumor cells, and can centrosomal analysis aid in the diagnosis and prognosis of breast carcinoma?
Conclusion
Structural centrosome amplification may be a potential biomarker for the diagnosis and prognosis of breast carcinoma.
Supporting Evidence
- Centrosome amplifications were found in most breast tumors.
- Cells with numerical centrosome amplification were found in 23 of 25 benign lesions and in all 75 cases of breast carcinomas.
- Structural centrosome amplification was found in 69 of 75 breast carcinomas.
- The mean percentage of cells with numerical centrosome amplification was significantly higher in breast carcinomas than in benign lesions.
- Structural centrosome amplification was significantly associated with HER2/neu overexpression and negative estrogen receptor status.
Takeaway
The study looked at breast tumor cells to see if they had extra centrosomes, which could help doctors tell if a tumor is cancerous or not.
Methodology
Immunofluorescence analysis was used to evaluate centrosome abnormalities in fine-needle aspirations of 100 breast lesions.
Limitations
The study may need larger sample sizes for more definitive conclusions.
Participant Demographics
The study included 100 breast lesions, with 25 benign and 75 malignant cases.
Statistical Information
P-Value
P < 0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website